Status:
COMPLETED
Effect of Two Doses of Coenzyme Q10 on Seminal Fluid and Semen Antioxidant Status
Lead Sponsor:
University of Sumer
Conditions:
Male Infertility
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The study was conducted to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men.
Detailed Description
The aim of this study was to assess the impact of two doses of coenzyme Q10 on seminal fluid parameters and antioxidant status in infertile men with idiopathic oligoasthenoteratospermia.
Eligibility Criteria
Inclusion
- History of infertility of at least 12 months despite regular unprotected intercourse.
- Oligoasthenoteratospermia was diagnosed by semen analysis showing abnormal sperm concentration (\<15 million/ml), progressive motility (\<32%), total motility (\<40%) and morphology (\<30% WHO criteria) as defined by WHO manual for semen analysis 2010
Exclusion
- Azoospermia,
- Varicocele,
- Genital tract infection,
- Cryptorchidism,
- Testicular trauma or scrotal surgery,
- Endocrine disorder,
- Systemic illness,
- Smoking
- The presence of female factor
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03850561
Start Date
June 1 2018
End Date
January 25 2019
Last Update
February 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Unit, Babyl
Hillah, Iraq, 00964